Vitamin B12: the forgotten micronutrient for critical care

Purpose of reviewTo analyse the anti-inflammatory and antioxidant properties of vitamin B12 and evaluate current evidence on vitamin B12 status in the critically ill with systemic inflammation. Recent findingsData on vitamin B12 status of intensive care unit patients are scarce. Cobalamins could potentially be useful agents for inhibiting nitric oxide synthase and nitric oxide production, controlling nuclear factor-kappa B activation, and restoring optimal bacteriostasis and phagocytosis in which transcobalamins play a proven role. The antioxidant properties of vitamin B12, with a glutathione-sparing effect, are secondary to stimulation of methionine synthase activity and reaction with free oxygen or nitrogen radicals. Large parenteral doses are routinely administered for cyanide poisoning, with only mild, reversible side-effects. Current evidence suggests that high-dose parenteral vitamin B12 may prove an innovative approach to treat critically ill systemic inflammatory response syndrome patients, especially those with severe sepsis/septic shock. In this setting, vitamin B12 and transcobalamins could modulate systemic inflammation contributing to the anti-inflammatory cascade and potentially improve outcome. SummaryDespite evidence from animal studies, so far there are no clinical intervention trials that have studied vitamin B12 as a pharmaconutrient strategy for critical care. Well designed animal and clinical studies are required to clarify several outstanding questions on the optimal posology, safety, and efficacy of high-dose vitamin B12 in the critically ill.

[1]  Joo-In Park,et al.  Relationship between the Levels of Holotranscobalamin and Vitamin B12. , 2010, The Korean journal of laboratory medicine.

[2]  C. Wheatley.  The return of the Scarlet Pimpernel: cobalamin in inflammation II — cobalamins can both selectively promote all three nitric oxide synthases (NOS), particularly iNOS and eNOS, and, as needed, selectively inhibit iNOS and nNOS , 2007, Journal of nutritional & environmental medicine.

[3]  S. Malnick,et al.  Association Between Vitamin B12 Levels and Mortality in Hospitalized Older Adults , 2010, Journal of the American Geriatrics Society.

[4]  W. Swaim,et al.  Hematologic Complications of Partial Gastrectomy , 1973, Annals of surgery.

[5]  K. Fearon,et al.  ESPEN Guidelines on Parenteral Nutrition: surgery. , 2009, Clinical nutrition.

[6]  C. Wheatley.  A scarlet pimpernel for the resolution of inflammation? The role of supra-therapeutic doses of cobalamin, in the treatment of systemic inflammatory response syndrome (SIRS), sepsis, severe sepsis, and septic or traumatic shock. , 2006, Medical hypotheses.

[7]  L. Allen.  How common is vitamin B-12 deficiency? , 2009, The American journal of clinical nutrition.

[8]  Y. Kosaka,et al.  Effects of methylcobalamin (vitamin B12) on in vitro cytokine production of peripheral blood mononuclear cells. , 1992, Journal of clinical & laboratory immunology.

[9]  B. Kr.  Vitamin B 12 : chemistry and biochemistry , 2005 .

[10]  K. Kurz,et al.  Early Increase of Plasma Homocysteine in Sepsis Patients with Poor Outcome , 2010, Molecular medicine.

[11]  A. Smith,et al.  Folic acid fortification: the good, the bad, and the puzzle of vitamin B-12. , 2007, The American journal of clinical nutrition.

[12]  J. Abilés,et al.  High prevalence of hyperhomocysteinemia in critically ill patients: Vascular damage and adequate vitamin intake , 2008 .

[13]  N. Jiang,et al.  Inhibition of nitric oxide synthase by cobalamins and cobinamides. , 2009, Free radical biology & medicine.

[14]  S. Lorenzl,et al.  Comparison of automated assays for the determination of vitamin B12 in serum. , 2007, Clinical biochemistry.

[15]  C. Wheatley.  Cobalamin in inflammation III — glutathionylcobalamin and methylcobalamin/adenosylcobalamin coenzymes: the sword in the stone? How cobalamin may directly regulate the nitric oxide synthases , 2007, Journal of nutritional & environmental medicine.

[16]  V. Lonchyna,et al.  Micronutrient supplementation in adult nutrition therapy: practical considerations. , 2009, JPEN. Journal of parenteral and enteral nutrition.

[17]  B. Kräutler.  Vitamin B12: chemistry and biochemistry. , 2005, Biochemical Society transactions.

[18]  M. Corwin,et al.  Nutritional deficiencies and blunted erythropoietin response as causes of the anemia of critical illness. , 2001, Journal of critical care.

[19]  P. Stover,et al.  Vitamin B12 and older adults , 2010, Current opinion in clinical nutrition and metabolic care.

[20]  G. Koren,et al.  Pharmacokinetics of high doses of cyanocobalamin administered by intravenous injection for 26 weeks in rats , 2005, Clinical and experimental pharmacology & physiology.

[21]  K. Ho,et al.  Inflammation, Vitamin Deficiencies and Organ Failure in Critically Ill Patients , 2009, Anaesthesia and intensive care.

[22]  K. Ho,et al.  Prevalence of Vitamin Deficiencies on Admission: Relationship to Hospital Mortality in Critically Ill Patients , 2009, Anaesthesia and intensive care.

[23]  G. Shepherd,et al.  Role of Hydroxocobalamin in Acute Cyanide Poisoning , 2008, The Annals of pharmacotherapy.

[24]  T. Walsh,et al.  Time course of anemia during six months follow up following intensive care discharge and factors associated with impaired recovery of erythropoiesis* , 2009, Critical care medicine.

[25]  G. Scalabrino.  Vitamin‐regulated cytokines and growth factors in the CNS and elsewhere , 2009, Journal of neurochemistry.

[26]  G. Hardy,et al.  High-dose selenium for critically ill patients with systemic inflammation: pharmacokinetics and pharmacodynamics of selenious acid: a pilot study. , 2010, Nutrition.

[27]  H. Delves.  Effect of inflammatory response on trace element and vitamin status. , 2001, Annals of clinical biochemistry.

[28]  V. Racca,et al.  Nutrition markers in patients after heart surgery. , 2010, JPEN. Journal of parenteral and enteral nutrition.

[29]  H. Lukaski.  Vitamin and mineral status: effects on physical performance. , 2004, Nutrition.

[30]  K. Eckardt,et al.  Important role of nondiagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients* , 1999, Critical care medicine.

[31]  A. Shenkin.  Basics in clinical nutrition: Trace elements and vitamins in parenteral and enteral nutrition , 2008 .

[32]  S. Hecht,et al.  Changes in blood pressure after administration of hydroxocobalamin: Relationship to changes in plasma cobalamins-(III) concentrations in healthy volunteers , 2008, Clinical toxicology.

[33]  H. McNulty,et al.  Studies of biomarker responses to intervention with vitamin B-12: a systematic review of randomized controlled trials. , 2009, The American journal of clinical nutrition.

[34]  B. Mégarbane,et al.  Hydroxocobalamin for severe acute cyanide poisoning by ingestion or inhalation. , 2007, The American journal of emergency medicine.

[35]  N. Bresolin,et al.  High tumor necrosis factor‐α in levels in cerebrospinal fluid of cobalamin‐deficient patients , 2004 .

[36]  C. Birch,et al.  A novel role for vitamin B(12): Cobalamins are intracellular antioxidants in vitro. , 2009, Free radical biology & medicine.

[37]  D. Veber,et al.  Indirect down‐regulation of nuclear NF‐κB levels by cobalamin in the spinal cord and liver of the rat , 2008, Journal of neuroscience research.

[38]  L. Solomon.  Disorders of cobalamin (vitamin B12) metabolism: emerging concepts in pathophysiology, diagnosis and treatment. , 2007, Blood reviews.